StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
6
Publishing Date
2023 - 10 - 24
1
2023 - 09 - 12
1
2023 - 05 - 17
1
2023 - 04 - 14
1
2022 - 09 - 20
1
2022 - 09 - 08
1
Sector
N/a
6
Tags
Agreement
1
Business
5
Conference
4
Congress
1
Day
2
Deadline
1
Drug
1
Fda
1
Financial
6
Glass
1
License
1
Lsd
1
Lysergide
1
Major depressive disorder
1
Meeting
4
Milestone
1
Mm-120
5
Mm-402
2
Momentum
1
N/a
37
Nasdaq
1
Offering
1
Phase 1
1
Phase 2
1
Positive
2
Preclinical
2
Presentation
1
Report
1
Results
6
Six
3
Technology
1
Today
1
Topline
1
Trial
6
Update
2
Year
1
Zydis
1
Entities
Mind medicine inc (sub voting)
6
Symbols
MNMD
6
Exchanges
Nasdaq
6
Crawled Date
2023 - 10 - 24
1
2023 - 09 - 12
1
2023 - 05 - 17
1
2023 - 04 - 14
1
2022 - 09 - 20
1
2022 - 09 - 08
1
Crawled Time
11:00
1
12:00
4
20:00
1
Source
alteritytherapeutics.com
16
alzamend.com
3
contravir.com
5
firstcobalt.com
4
investor.assemblybio.com
3
investors.biomarin.com
2
ir.akerotx.com
2
ir.anaptysbio.com
2
ir.auriniapharma.com
2
ir.benitec.com
2
ir.biolinerx.com
6
ir.hoththerapeutics.com
5
ir.kalvista.com
3
ir.opgen.com
2
ir.radiuspharm.com
3
ir.vaccinex.com
2
ir.viveve.com
6
ir.zynerba.com
2
jaguarhealth.gcs-web.com
5
mindmed.co
6
neurosense.investorroom.com
6
ocutx.gcs-web.com
3
renovorx.com
2
spacfeed.com
9
velodynelidar.com
9
www.4dpharmaplc.com
6
www.achievelifesciences.com
5
www.adnas.com
4
www.agtc.com
5
www.akerotx.com
3
www.allogene.com
2
www.anaptysbio.com
3
www.anavex.com
4
www.aquestive.com
3
www.athira.com
3
www.atyrpharma.com
3
www.balchem.com
2
www.biolase.com
2
www.biospace.com
2761
www.brainsway.com
3
www.celyad.com
3
www.chi-med.com
2
www.daxor.com
2
www.fatetherapeutics.com
6
www.fda.gov
7
www.fsdpharma.com
5
www.globenewswire.com
2286
www.hancockjaffe.com
3
www.igcinc.us
6
www.inovio.com
8
www.inventivapharma.com
5
www.nantkwest.com
7
www.novocure.com
5
www.nurixtx.com
5
www.ppdi.com
4
www.prnewswire.com
1442
www.stagindustrial.com
21
www.veeva.com
3
www.vynetherapeutics.com
4
www.zynerba.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Trial
source :
Mindmed.co
save search
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
Published:
2023-10-24
(Crawled : 12:00)
- mindmed.co
MNMD
|
$8.885
2.36%
2.31%
1.2M
|
n/a
|
230.04%
|
O:
2.28%
H:
3.72%
C:
0.74%
mm-120
trial
MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
Published:
2023-09-12
(Crawled : 12:00)
- mindmed.co
MNMD
|
$8.885
2.36%
2.31%
1.2M
|
n/a
|
101.39%
|
O:
0.7%
H:
3.92%
C:
-2.76%
mm-120
trial
MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
Published:
2023-05-17
(Crawled : 20:00)
- mindmed.co
MNMD
|
$8.885
2.36%
2.31%
1.2M
|
n/a
|
175.56%
|
O:
0.63%
H:
5.05%
C:
-0.63%
mm-120
trial
milestone
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
Published:
2023-04-14
(Crawled : 11:00)
- mindmed.co
MNMD
|
$8.885
2.36%
2.31%
1.2M
|
n/a
|
180.0%
|
O:
22.58%
H:
1.05%
C:
-16.84%
positive
topline
trial
lsd
lysergide
major depressive disorder
phase 2
MindMed Collaborators Dose First Subject in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances
Published:
2022-09-20
(Crawled : 12:00)
- mindmed.co
MNMD
|
$8.885
2.36%
2.31%
1.2M
|
n/a
|
17.3%
|
O:
-0.68%
H:
0.41%
C:
-4.76%
trial
phase 1
MindMed Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal
Published:
2022-09-08
(Crawled : 12:00)
- mindmed.co
MNMD
|
$8.885
2.36%
2.31%
1.2M
|
n/a
|
2.97%
|
O:
2.02%
H:
7.67%
C:
7.33%
trial
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.